All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

Schistosomiasis is a neglected disease caused by the parasitic trematode *Schistosoma*. Reported in over 70 tropical and subtropical countries or territories, schistosomiasis is known to affect approximately 240 million people, and more than 700 people live in endemic areas \[[@pone.0198476.ref001]\]. Infection is prevalent in poorer communities throughout tropical and subtropical areas. Praziquantel, the only drug available to control the disease, was developed in the 1970s and has been shown to be ineffective against the larval stage of the parasite, with concerns about drug resistance. The search for new drugs, mainly from natural resources \[[@pone.0198476.ref002]--[@pone.0198476.ref003]\], is therefore of interest.

The interdisciplinary study of neglected diseases and medicinal chemistry is a new area of research that involves the rational planning, evaluation, and synthesis of new drugs in addition to the interpretation of their mode of action at the molecular level and the determination of biological effects arising from their molecular structures \[[@pone.0198476.ref004]\]. To complement this area of study, computational quantum chemistry has developed new tools to enable modeling and molecular dynamics studies that simulate biological tests and create new possibilities for drug models, without the need for solvent and reagent wastage \[[@pone.0198476.ref005]--[@pone.0198476.ref009]\].

Molecular docking is widely used to predict protein-ligand complexes and to screen large libraries for molecules that will modulate the activity of a biological receptor. Molecular docking remains an important tool for structure-based screening to find new ligands and chemical probes, it has enriched hit-rates and often confirming the predicted geometries of the docked complex \[[@pone.0198476.ref010]--[@pone.0198476.ref011]\]. The importance of optimizing the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of compounds in addition to pharmacology increase drug discovery success. This sufficiently acceptable toxicity properties to success through the of human Phase I clinical trials. Intrinsic properties of the molecules and it is responsibility of the medicinal chemistry to optimize not only the pharmacological properties but also the drug-like properties of these molecules \[[@pone.0198476.ref012]--[@pone.0198476.ref013]\].

Among the candidates for new drugs are the imidazole alkaloids present in the species *Pilocarpus microphyllus* Stapf ex Holm. (Rutaceae), which have been noted in the literature for their pharmacological action against schistosomiasis \[[@pone.0198476.ref014]--[@pone.0198476.ref017]\]. However, little is known about their mode of action. These alkaloids, which are secondary metabolites found mainly in plants, mainly function as a defense against predators and pathogens.

Of the *P*. *microphyllus* alkaloids used in this study, epiisopiloturine (EPI) is the best characterized. EPI was identified in the 1970s \[[@pone.0198476.ref018]\] and its subsequent isolation and chemical characterization revealed strong pharmacological potency against *S*. *mansoni* \[[@pone.0198476.ref017],[@pone.0198476.ref019],[@pone.0198476.ref020]--[@pone.0198476.ref021]\]. Other biological functions have been described, including anti-inflammatory, anti-contraceptive \[[@pone.0198476.ref022]\], and gastro-protective effects \[[@pone.0198476.ref023]\]. The pharmacological action of epiisopilosine (EPIIS) and isopilosine (ISOP) against *S*. *mansoni* has also been described \[[@pone.0198476.ref016]\]. Macaubine (MAC) is the only alkaloid to show no effect against schistosomiasis \[[@pone.0198476.ref016]\], although pilosine (PILO) has not yet been tested.

Among these alkaloids in this study, little is known about their mechanism of action against *S*. *mansoni*; how these molecules interact with the possible enzymes of the worm, which pharmacological reactions are triggered; and how their chemical structures provide effective biological activity against this disease. As there is only a single drug used for treatment, with a high concern about associated resistance, we were motivated to apply the potential of computational quantum chemistry to the problem of this neglected disease. Thus, the main objective of the paper is to perform a theoretical study, in density functional theory (DFT) level, with geometry, electronic, and vibrational properties, molecular docking and absorption, distribution, metabolization, excretion, and toxicity (ADMET) predictions of the imizadole alkaloids of *P*. *microphyllus* with schistosomicidal properties.

Materials and methods {#sec002}
=====================

Computational details {#sec003}
---------------------

Alkaloid geometry, electronic, and vibrational properties were studied using the program Gaussian 09 \[[@pone.0198476.ref024]\]. The GaussView 5.0.8 \[[@pone.0198476.ref025]\] software was used to obtain 3D structural models. Geometric optimization calculations were performed in accordance with DFT \[[@pone.0198476.ref026]\] by combining the B3LYP \[[@pone.0198476.ref027]--[@pone.0198476.ref028]\] functional hybrid and basis sets SDD, 6--31+g(d,p), and 6--311++g(d,p) \[[@pone.0198476.ref029]--[@pone.0198476.ref030]\]. Frequency calculations were performed to obtain thermodynamic properties and to verify that each optimization achieved an energy minimum.

The quantum chemical descriptors extracted directly from the Gaussian output file were Mulliken, NBO and ChelpG charge, electronic density, dipole moment, the energy of the highest occupied molecular orbital (E~HOMO~), and the energy of the lowest unoccupied molecular orbital (E~LUMO~) \[[@pone.0198476.ref031]--[@pone.0198476.ref032]\]. All calculations were performed in the gas phase. Time-dependent density functional theory (TDDFT) was used to calculate the energies and intensities of electronic transitions \[[@pone.0198476.ref033]--[@pone.0198476.ref034]\]. The calculated electronic transitions, infrared, and Raman spectra were convoluted by using Gaussian functions with half-widths of 25.000 cm^-1^ computed by the Swizard program \[[@pone.0198476.ref035]\].

ADMET predictions {#sec004}
-----------------

The prediction of pharmaceutical parameters was conducted using the freely available pre-ADMET® and FAF-Drugs4® software packages. The in sílico methodology used with the EPI, EPIIS, ISOP, PILO, and MAC molecules included physical--chemical parameters, drug-likeness profile, pharmacokinetic profile (ADME), and toxicity. Among the most relevant parameters of absorption were the observation of the ability of the drug to cross the blood-brain barrier (BBB), as well as the drug absorption rate (Caco2), the rate of absorption by human intestinal cells (HIA) and excretion (MDCK). Regarding the metabolization process, the capacity of inhibition, non-inhibition and substrate formation by the molecules through their behavior on CYP-450 subfamilies was evaluated \[[@pone.0198476.ref012]--[@pone.0198476.ref013]\].

Molecular docking {#sec005}
-----------------

The 3D structures of all possible *S*. *mansoni* targets were obtained from the Protein Data Bank (PDB) \[[@pone.0198476.ref036]\] with the codes (3QSD, 4Q3P, 4CQF, 4L5A, 1TCU, 2V6O, and 4TXH). All docking procedures utilized the Autodock 4.2 package \[[@pone.0198476.ref037]--[@pone.0198476.ref039]\]. Protein (ACE) and ligands were prepared for docking simulations with AutoDock Tools (ADT) version 1.5.6. \[[@pone.0198476.ref040]\]. The receptor was considered rigid; each ligand was considered flexible. Gasteiger \[[@pone.0198476.ref041]\] partial charges were calculated after the addition of all hydrogens. Nonpolar hydrogen atoms of the protein and ligand were subsequently merged. A cubic box of 60 × 60 × 60 points with a spacing of 0.35 Å between the grid points was generated for the whole protein target. The affinity grid centers were defined on residue Asp158 for ARG, Ala118 for PNP, Asp230 for MTAP, Tyr341 for HDAC8, Gln201 for UP, Tyr296 for TGR, and Cys100 for 2CB1. The global search Lamarckian genetic algorithm (LGA) \[[@pone.0198476.ref042]\] and the local search (LS) pseudo-Solis and Wets \[[@pone.0198476.ref043]\] methods were applied in the docking search. Each ligand was subjected to 100 independent runs of docking simulations \[[@pone.0198476.ref044]\]. Other docking parameters were set as the default values. The resulting docked conformations were clustered into families according to the RMSD. For a more detailed analysis, the coordinates of the selected complexes were chosen by the criterion of lowest docking conformation of the cluster with lowest energy in combination with a visual inspection.

Results and discussion {#sec006}
======================

Computational details {#sec007}
---------------------

The imidazole alkaloids used in this study have the chemical structure shown in [Fig 1](#pone.0198476.g001){ref-type="fig"}. It is possible to observe four isomeric forms between the EPI, EPIIS, ISOP, and PILO alkaloids (C~16~H~18~N~2~O~3~), and the presence of optical isomerism between the EPIIS, ISOP, and PILO alkaloids, which is expressly observed in the rotation of the C4 and C9 atoms (conformers), and in the chiral carbons C5, C7, and C8, which corroborate with data previously presented in experimental studies \[[@pone.0198476.ref016]\].

![Optimized chemical structures of alkaloids.\
a) epiisopiloturine, b) epiisopilosine, c) isopilosine, d) pilosine, and e) macaubine.](pone.0198476.g001){#pone.0198476.g001}

### Charges study {#sec008}

The atomic charges of the alkaloids under study are shown in [Table 1](#pone.0198476.t001){ref-type="table"} for the theoretical model B3lyp/6-311++G(d,p). The bond between C2-N1 is covalent, so electrons are shared between them. However, the nitrogen atom is more electronegative and attracts more electronic density to itself, which concentrates the electron density. The NBO loads in all binders (EPI, EPIIS, ISOP, PILO, and MAC) had negative charge values, whereas for the Chelpg and Mulliken methods, the loads were predicted to be positive ([Table 1](#pone.0198476.t001){ref-type="table"}). All other models are shown in [S1](#pone.0198476.s001){ref-type="supplementary-material"} and [S2](#pone.0198476.s002){ref-type="supplementary-material"} Tables.

10.1371/journal.pone.0198476.t001

###### Atomic charges (in atomic unit, a.u.) by the Mulliken, Chelpg, and NBO methods of the epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine alkaloids using the theoretical model B3lyp/6-311++G(d,p).

![](pone.0198476.t001){#pone.0198476.t001g}

            EPI      EPIIS    ISOP     PILO     MAC                                                                                       
  --------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------
  **N1**    0.105    -0.406   0.017    0.063    -0.415   0.005    0.115    -0.415   0.014    0.113    -0.417   0.005    0.098    -0.414   -0.003
  **N2**    -0.577   -0.513   0.096    -0.562   -0.492   -0.104   -0.572   -0.493   -0.099   -0.592   -0.492   -0.110   -0.543   -0.490   -0.107
  **O1**    -0.456   -0.547   -0.009   -0.429   -0.544   -0.016   -0.414   -0.543   -0.023   -0.441   -0.547   -0.025   -0.452   -0.543   -0.088
  **O2**    -0.572   -0.576   -0.256   -0.526   -0.564   -0.291   -0.522   -0.565   -0.284   -0.545   -0.566   -0.275   -0.548   -0.570   -0.307
  **O3**    -0.564   -0.746   -0.207   -0.593   -0.741   -0.210   -0.541   -0.751   -0.142   -0.568   -0.735   -0.177   \-       \-       \-
  **C1**    0.115    0.218    0.259    0.188    0.211    0.081    0.197    0.208    0.113    0.190    0.208    0.077    0.174    0.214    0.085
  **C2**    -0.163   -0.347   -0.316   -0.276   -0.352   -0.303   -0.371   -0.352   -0.325   -0.370   -0.350   -0.293   -0.277   -0.353   -0.389
  **C3**    0.439    0.108    0.175    -0.062   0.109    0.467    -0.153   0.112    0.592    -0.182   0.114    0.178    -0.130   0.109    0.481
  **C4**    -0.377   -0.401   -0.984   -0.234   -0.410   -0.694   -0.056   -0.417   -0.792   -0.010   -0.428   -0.341   0.068    -0.447   -1.043
  **C5**    0.223    -0.242   0.079    0.237    -0.240   0.005    0.187    -0.231   -0.095   0.099    -0.223   0.164    0.015    0.024    0.607
  **C6**    0.695    0.817    -0.221   0.639    0.828    -0.060   0.614    0.818    -0.206   0.667    0.822    -0.002   0.741    0.775    -0.071
  **C7**    0.114    -0.319   -0.182   0.123    -0.318   0.082    0.067    -0.318   0.285    0.221    -0.325   -0.463   -0.169   -0.129   0.335
  **C8**    0.145    0.139    0.298    0.108    0.132    0.152    -0.073   0.133    -0.284   -0.014   0.130    0.183    -0.102   -0.600   -0.545
  **C9**    0.091    -0.075   0.767    0.104    -0.075   0.515    0.192    -0.075   1.016    0.156    -0.077   0.706    \-       \-       \-
  **C10**   -0.177   -0.199   -0.319   -0.163   -0.202   -0.034   -0.158   -0.201   -0.231   -0.161   -0.202   -0.110   \-       \-       \-
  **C11**   -0.051   -0.200   -0.311   -0.058   -0.200   -0.432   -0.076   -0.198   -0.511   -0.083   -0.200   -0.451   \-       \-       \-
  **C12**   -0.118   -0.200   -0.446   -0.114   -0.199   -0.339   -0.106   -0.196   -0.382   -0.100   -0.199   -0.351   \-       \-       \-

The observation of the bond between O2 = C6-O1 revealed that the charges were not well described using the Mulliken method as there was consistency between these charges, and because they have negative values for all atoms in the bond, including C7. The nature of the type of binding may be the determining factor in these charges, which the Mulliken method cannot accurately describe ([Table 1](#pone.0198476.t001){ref-type="table"}). The NBO method again described the load on this connection.

The bond length C8-O3 showed negative values for all ligands for the O3 atom in the three types of charges tested. In contrast, C8 always presented NBO with a positive charge, independent of the isomer. However, in the ISOP and PILO isomers with the Chelpg and Mulliken methods, negative charges were presented which did not corroborate with the NBO and the electronegativity of the atoms themselves ([Table 1](#pone.0198476.t001){ref-type="table"}).

### Atomic distances analysis {#sec009}

The binding lengths and binding angles calculated in the three theoretical models showed a small decrease in values with an increase in the number of base functions ([S3 Table](#pone.0198476.s003){ref-type="supplementary-material"}), except for the EPI alkaloid, which had the same values in B3lyp/6-31+G(d,p) and B3lyp/6-311++G(d,p) ([Table 2](#pone.0198476.t002){ref-type="table"}).

10.1371/journal.pone.0198476.t002

###### Distances of the atomic bonds (Å), atomic angles, and dihedral angles (°) of the alkaloids epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine using the theoretical model B3lyp/6-311++G(d,p).

![](pone.0198476.t002){#pone.0198476.t002g}

  B3lyp/6-311++G(d,p)   EPI     EPIIS   ISOP    PILO    MAC
  --------------------- ------- ------- ------- ------- -------
  N1 --C2               1.454   1.454   1.455   1.453   1.455
  N2 --C1               1.317   1.311   1.312   1.311   1.312
  O2 = C6               1.207   1.196   1.198   1.197   1.201
  O1 --C6               1.356   1.360   1.356   1.360   1.371
  O3 --C8               1.432   1.429   1.440   1.427   \-
  N1 --C1 --N2          112.3   112.3   112.3   112.3   112.3
  C1 --N1 --C2          126.9   125.7   125.8   125.7   126.0
  C3 --C4 --C5          113.3   114.5   114.3   113.7   114.3
  O2 = C6---O1          122.2   121.9   122.1   121.9   122.7
  O3 --C8 --C7          106.3   106.5   106.3   108.0   \-
  C7 --C8 --C9          115.1   115.4   114.1   114.3   \-
  C8 --C9 --C10         119.2   119.0   120.4   119.1   \-
  C4 --C5 --C7 --C8     140.7   82.4    88.2    41.2    \-
  C5 --C7 --C8 --O3     63.3    62.2    −45.0   −75.1   \-

Among the alkaloids studied, a highly regular chemical structure was observed in the imidazolic ring, with similar distances for N1-C2 and N2-C1 and similar angles for N1-C1-N2 and C1-N1-C2; only EPI had a slight variation of 1°.

In the dihydrofuran ring, the atomic angles between O = C6-O1 were similar in EPI, ISOP, and MAC (122.2°), and between EPIIS and PILO (121.9°). The distance of the atomic double bond between O2 = C6 was higher in EPI (1.207 Å) and lower in EPIIS (1.196 Å). The length of the O1-C6 bond had similar values in EPIIS and PILO (1.360 Å) and EPI and ISOP (1.356 Å). In the benzene ring, the internal angles were highly similar, with only a small variation of 1° in ISOP.

Through the observation of the chiral C8, which links the benzene ring to the dihydrofuran ring, it was observed that the O3-C8 distance was higher in ISOP (1.440 Å) and lower in PILO (1.427 Å). The angle between O3-C8-C7 was also higher in PILO (108.0°), but similar in the other alkaloids (106.3°) and (106.5°). In addition, it was possible to observe an expressive variation in the dihedral angle in the C4-C5-C7-C8 atoms between the optically symmetric EPIIS (82.4°), ISOP (88.2°), and PILO (41.2°) and the C5-C7-C8-O3 atoms of EPIIS (62.2°), ISOP (−45.0°), and PILO (−75.1°) ([Table 2](#pone.0198476.t002){ref-type="table"}).

The experimental X-ray results of a macrophage of the MAC alkaloid were defined \[[@pone.0198476.ref016]\], where similarities in the distances of the chemical bonds presented in our theoretical calculations were found in N1-C2 (1.448 Å), N2-C1 (1.318 Å), O2 = C6 (1.210 Å), C6-O1 (1.350 Å), N1-C1-N2 (108.3°).

### Relative energies study {#sec010}

The relative energies between the isomeric alkaloids demonstrated that the EPI alkaloid was more stable than the others compounds ([Fig 2](#pone.0198476.g002){ref-type="fig"}; [S4 Table](#pone.0198476.s004){ref-type="supplementary-material"}). In the three theoretical models, the energy ranking was similar. However, as expected, the B3lyp/6-311++G(d,p) model showed that EPI was more stable between isomers compared with ISOP, by approximately 1.79 kcal mol^-1^, followed by EPIIS (3.29 kcal mol^-1^) and PILO (6.16 kcal mol^-1^). The stability may suggest a greater number of alkaloids among the studied isomers. The chemical structure of these alkaloid isomers is evidence of the difference in their stability across the dihedral angles ([Table 2](#pone.0198476.t002){ref-type="table"}); by acquiring a cis conformation, the PILO alkaloid tends to be less stable compared with EPI, which is the most stable, given of its trans configuration. In this way, chemical reactions induced by light, temperature, or electricity \[[@pone.0198476.ref045]\] could easily result in the conversion of these less-stable models to more trans models, such as ISOP, which is isomeric with PILO, by changing conformation.

![Relative energies in (kcal mol^-1^) of alkaloids isomers of EPI by theoretical models B3lyp/SDD (I), B3lyp/6-31+G(d,p) (II), and B3lyp/6-311++G(d,p) (III).\
a) epiisopiloturine, b) epiisopilosine, c) isopilosine and d) pilosine.](pone.0198476.g002){#pone.0198476.g002}

### Orbitals molecular predictions {#sec011}

The analysis of molecular orbitals showed a pattern in the values between alkaloids in the three models studied, with a small decrease in values in relation to the increase in the base functions ([S5 Table](#pone.0198476.s005){ref-type="supplementary-material"}). The analysis of the results obtained in the B3lyp/6-311++G(d,p) model revealed that the energy gaps were very close, with higher values of gap energy in EPI (5.85 eV) and smaller values in MAC (5.13 eV). The EPIIS, ISOP, and PILO optical isomers had gap values of 5.61 eV, 5.38 eV, and 5.46 eV, respectively ([Fig 3](#pone.0198476.g003){ref-type="fig"}).

![Graphic of the molecular orbitals HOMO and LUMO of the epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine alkaloids using the theoretical model B3lyp/6-311++G(d,p).](pone.0198476.g003){#pone.0198476.g003}

The distance between LUMO+1 and HOMO-1 tended to increase in relation to the decrease in gap energy, from EPI to MAC. The proximity between the orbitals facilitates the interaction between the electrons, as observed in EPI (6.24 eV), EPIIS (6.26 eV), PILO (6.26 eV), ISOP (6.43 eV), and MAC (6.93 eV) ([Fig 3](#pone.0198476.g003){ref-type="fig"}). The molecular boundary orbitals HOMO and LUMO are responsible for the biological interactions between ligands and proteins \[[@pone.0198476.ref046]--[@pone.0198476.ref048]\]

The energy quantum jumps between the molecular orbits of the alkaloids were quantified ([Table 3](#pone.0198476.t003){ref-type="table"}, [Fig 4](#pone.0198476.g004){ref-type="fig"}). For the EPI alkaloid, the highest value of the oscillator force was 0.0229 at a wavelength in the range of 230 nm and showed a jump between 73 (HOMO-3) and 77 (LUMO), with a gap of 6.66 eV. For the EPIIS alkaloid, the highest value of the oscillator force was 0.0150 at 237 nm and showed a jump between 75 (HOMO-1) → 77 (LUMO), with a gap of 6.17 eV. For the ISOP alkaloid, the highest value of the oscillator force was 0.0203 at 249 nm and showed a jump between 76 (HOMO) → 77 (LUMO), with a gap of 5.38 eV. For the PILO alkaloid, the highest value of the oscillator strength was 0.0034 at 236 nm and showed a jump between 76 (HOMO) → 79 (LUMO+2), with a gap of 5.62 eV. For MAC, the highest value of the oscillator force was 0.0139 and showed a jump between 51 (HOMO) → 52 (LUMO) with a gap of 5.13 eV ([Table 3](#pone.0198476.t003){ref-type="table"}, [Fig 4](#pone.0198476.g004){ref-type="fig"}). This TD-DFT approach is considered reliable for describing geometries and spectral properties \[[@pone.0198476.ref049]\].

![The molecular orbitals HOMO and LUMO of the epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine alkaloids calculated using the theoretical model B3lyp/6-311++G(d,p) in the Swizard program.](pone.0198476.g004){#pone.0198476.g004}

10.1371/journal.pone.0198476.t003

###### Main assignments of the bands of the electronic spectrum of UV-Vis, energy, and types, calculated using the Swizard program for the molecular forms epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine.

I = imidazole, D = dihydrofuran, B = benzene.

![](pone.0198476.t003){#pone.0198476.t003g}

  Wavelength (nm) / Strength of the oscillator \[f\]   Composition   Energy (eV)   Type of charge transfer
  ---------------------------------------------------- ------------- ------------- -------------------------
  EPI                                                                              
  238 \[0.0084\]                                       75→79 (28%)   5.20          CT BD-I
  237 \[0.0021\]                                       76→78 (95%)   5.23          CT I-B
  230 \[0.0229\]                                       73→77 (18%)   5.38          CT BD-BD
  EPIIS                                                                            
  244 \[0.0057\]                                       76→78 (91%)   5.08          CT I-B
  238 \[0.0008\]                                       76→77 (57%)   5.20          CT I-B
  237 \[0.0150\]                                       75→77 (37%)   5.23          CT BD-B
  ISOP                                                                             
  249 \[0.0203\]                                       76→77 (91%)   4.96          CT I-B
  243 \[0.0002\]                                       76→79 (62%)   5.10          CT I-I
  237 \[0.0042\]                                       74→77 (37%)   5.23          CT I-B
  PILO                                                                             
  253 \[0.0026\]                                       76→77 (49%)   4.89          CT I-B
  243 \[0.0034\]                                       76→78 (49%)   5.09          CT I-B
  236 \[0.0034\]                                       76→79 (24%)   5.23          CT I-I
  MAC                                                                              
  281 \[0.0139\]                                       51→52 (98%)   4.40          CT I-D
  253 \[0.0004\]                                       49→52 (38%)   4.90          CT I-D
  237 \[0.0010\]                                       51→53 (97%)   5.23          CT I-I

The results obtained for the energy jumps corroborated with the results obtained from the UV-Vis spectra ([Fig 5](#pone.0198476.g005){ref-type="fig"}), where the graph peak represents the same values of the molecular orbitals. Spectroscopic UV-Vis data showed absorption bands at 230 nm for EPI, 237 nm (EPIIS), 249 nm (EPIIS), 243 nm (PILO), and 281 nm (MAC) using the theoretical model B3lyp/6-311++G(d,p). The theoretical model B3lyp/6-31+G(d,p) was highly similar, and the B3lyp/SDD model showed a more distant wavelength than these two models ([S1 Fig](#pone.0198476.s009){ref-type="supplementary-material"}).

![UV-Vis spectrum of the epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine alkaloids using the theoretical model B3lyp/6-311++G(d,p).](pone.0198476.g005){#pone.0198476.g005}

### Spectral analysis {#sec012}

The infrared spectra are shown in [S8 Table](#pone.0198476.s008){ref-type="supplementary-material"}. Similarities can be observed in the vibrational frequencies between the EPI, EPIIS, ISOP, and PILO alkaloids, which demonstrate the isomeric conformations (Figs (a) and (b) in [S2 Fig](#pone.0198476.s010){ref-type="supplementary-material"}. The symmetric carbonyl stretching (C = O) showed a strong peak in the regions of 1785 cm^-1^, 1846 cm^-1^, 1838 cm^-1^, and 1845 cm^-1^ for EPI, EPIIS, ISOP, and PILO, respectively. A deformation in the dihydrofuran ring represented the second highest intensity, at a frequency between 1075 cm^-1^ and 1162 cm^-1^ in all alkaloids. This was followed by C-N stretching and C-H group deformation, which occurred at frequencies between 1404 cm^-1^ and 1455 cm^-1^, respectively, in all alkaloids. The OH group showed a strong peak in the region of 3783 cm^-1^ to 3830 cm^-1^. This peak was absent in MAC, because it does not contain an OH group in its structure ([S8 Table](#pone.0198476.s008){ref-type="supplementary-material"}). The lowest values of the IR frequencies were identified in PILO, which corroborated the results presented in [Fig 2](#pone.0198476.g002){ref-type="fig"} that demonstrated a lower stability for this alkaloid ([S8 Table](#pone.0198476.s008){ref-type="supplementary-material"}). For the IR and Raman parameters, the theoretical model B3lyp/6-31+G(d,p) was highly similar to the B3lyp/6-311++G(d,p), and the B3lyp/Sdd model indicated a more distant wavenumber than these two models ([S3](#pone.0198476.s011){ref-type="supplementary-material"} and [S4](#pone.0198476.s012){ref-type="supplementary-material"} Figs).

The experimental IR data for the EPI alkaloid have been previously described \[[@pone.0198476.ref019]\], including C = O stretching in dihydrofuran (1769 cm^-1^), C-C stretching in imidazole (1568 cm^-1^), symmetric stretching N-C-N in imidazole (1524 cm^-1^), and C-C stretching in benzene (1472 cm^-1^), which showed a greater similarity to our theoretical parameters compared with those used by the author, which supported the use of the same theoretical model. This difference might have resulted from the optimization of the chemical structure of EPI used differently in both works.

The theoretical ^13^C NMR spectra of the EPI, EPIIS, ISOP, PILO, and MAC alkaloids are shown in [S5 Fig](#pone.0198476.s013){ref-type="supplementary-material"}, as well as the chemical shift patterns ([S6 Table](#pone.0198476.s006){ref-type="supplementary-material"}). The ^13^C NMR spectrum of EPI shows the peaks related to the CH~3~ and CH~2~ groups (C2 and C4) at 33--37 ppm and CH (C8) at 85 ppm, where the latter exhibits a hydroxyl group, unlike C4. The C1 and C3 (143--151 ppm) of the imidazole ring were displaced, owing to the resonance of the aromatic ring. In addition, the resonance peaks at 131--134 ppm related to CH bonds (C10, C11, C12, C13, and C14) in benzene were observed to be slightly less displaced than the C1 and C3 of the imidazole aromatic ring. Finally, a downfield shift for C6 in the dihydrofuran ring was observed, which was displaced by the binding to the oxygen atom, whereas the CH~2~ (C15) directly bound to the CO (carbonyl group) and C7 (CH) were protected by the ring. As the EPI, EPIIS, ISOP and PILO alkaloids exhibit isomerism, similarities were observed in the values of the displacement patterns ([S5 Fig](#pone.0198476.s013){ref-type="supplementary-material"}; [S6 Table](#pone.0198476.s006){ref-type="supplementary-material"}).

The experimental results of ^13^C NMR of EPI, EPIIS, ISOP, PILO, and MAC presented in previous studies \[[@pone.0198476.ref016], [@pone.0198476.ref019]\] describe patterns of displacement similar to that obtained in our calculations, with peaks of (179, 137, 32, 125--128 ppm) for EPI, (180, 139, 31, 126--129 ppm) for EPIIS, (179, 139, 31, 127--129 ppm) for ISOP, (179, 139, 31, 127--129 ppm) for PILO, and (178, 135, and 33 ppm) for MAC.

### Electronic density {#sec013}

The dipole moment calculations presented in the three theoretical models showed closer values between the B3lyp/6-311++G(d,p) and B3lyp/6-31+G(d,p) models. The data generated for all alkaloids using the B3lyp/6-311++G(d,p) model did result in significant differences because of the markedly close values of parameters; differences in the house of 0.2 debye, PILO (7.3 debye), EPI (5.8 debye), EPIIS (5.7 debye), ISOP (5,3 debye), and MAC (4.5 debye) are presented in [S7 Table](#pone.0198476.s007){ref-type="supplementary-material"}. These values also suggest a similar solubility potential.

For the electron density in each molecule, it was observed that redder regions are more negative and therefore more polar; this was observed in the imidazolic ring by the N1 atom and in the O = C group of the dihydrofuran ring in all the alkaloids ([Fig 6](#pone.0198476.g006){ref-type="fig"}). These regions with higher electronic density also represented sites with a higher probability of chemical interactions, described in molecular docking.

![Electronic density of alkaloids.\
a) epiisopiloturine, b) epiisopilosine, c) isopilosine, d) pilosine, and e) macaubine, using the theoretical model B3lyp/6-311++G(d,p). The colors represent red (negative) and blue (positive).](pone.0198476.g006){#pone.0198476.g006}

ADMET predictions {#sec014}
-----------------

The theoretical prediction of pharmacokinetics in sílico is an approach that is currently used widely in the initial study of the ADMET properties to reduce unnecessary expense in biological assays of compounds with a high probability of pharmacokinetic problems, which saves on time and investment \[[@pone.0198476.ref050]\].

ADMET analysis for the alkaloids produced the same values for the EPIIS, ISOP and PILO optical isomers, which assigned all three the same prediction in [Table 4](#pone.0198476.t004){ref-type="table"}. Through analysis of the plasma protein binding property (PPB), similar values were found for the EPI, EPIIS, ISOP, and PILO isomers (63%), with a lower value found for the MAC alkaloid (37%). The results of the penetration potential in the blood--brain barrier (BBB) showed that the compounds have low potential to cross the blood--brain barrier, indicated by values below 0.1 \[[@pone.0198476.ref051]\]; the obtained values were 0.011 (EPI), 0.016 (EPIIS), and 0.992 (MAC), indicating that these compounds were less likely to cause side effects in the central nervous system \[[@pone.0198476.ref052]\].

10.1371/journal.pone.0198476.t004

###### ADMET predictions of the epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine alkaloids.

![](pone.0198476.t004){#pone.0198476.t004g}

  ADMET                                                       EPI                          EPIIS/ISOP/PILO              MAC
  ----------------------------------------------------------- ---------------------------- ---------------------------- -------------------
  Plasma protein binding (PPB) (%)                            63.140757                    63.940875                    37.146972
  Blood-brain barrier penetration (BBB) (C, brain/C, blood)   0.011675                     0.0167958                    0.992212
  Skin Permeability (logKp, cm/h)                             -3.86369                     -3.89764                     -3.0451
  Human intestinal absorption (HIA, %)                        96.050121                    96.050121                    97.523105
  Caco-2 cell Permeability (nm/s)                             21.8393                      22.8681                      27.2895
  MDCK cell permeability (nm/s)                               16.0498                      9.63097                      15.7929
  P-glycoprotein inhibition                                   Non                          Non                          Non
  Water solubility in buffer (mg/L)                           23332.8                      78158.6                      3810.15
  Pure water solubility (mg/L)                                8525.04                      21880                        110732
  Ames test                                                   Mutagen                      Mutagen                      Mutagen
  Ames TA100 (+S9)                                            Negative                     Negative                     Positive
  Ames TA100 (-S9)                                            Negative                     Negative                     Positive
  Ames TA1535 (+S9)                                           Negative                     Negative                     Positive
  Ames TA1535 (-S9)                                           Negative                     Negative                     Positive
  Carcinogenicity (Mouse)                                     Negative                     Negative                     Negative
  Carcinogenicity (Rat)                                       Negative                     Negative                     Negative
  CYP 2C19 inhibition                                         Inhibitor                    Inhibitor                    Inhibitor
  CYP 2C9 inhibition                                          Inhibitor                    Inhibitor                    Inhibitor
  CYP 2D6 inhibition                                          Non                          Non                          Non
  CYP 2D6 substrate                                           Non                          Non                          Weakly
  CYP 3A4 inhibition                                          Inhibitor                    Inhibitor                    Inhibitor
  CYP 3A4 substrate                                           Substrate                    Substrate                    Substrate
  Lipinski's Rule                                             Suitable                     Suitable                     Suitable
  WDI-like Rule                                               Within 90% cutoff            Within 90% cutoff            Within 90% cutoff
  Lead-like Rule                                              Binding affinity \> 0.1 μM   Binding affinity \> 0.1 μM   Violated
  CMC-like Rule                                               Qualified                    Qualified                    Qualified
  MDDR-like Rule                                              Mid-structure                Mid-structure                Mid-structure

The values the permeability through human skin were −3.863 cm/h (EPI), −3.897 cm/h (EPIIS), and −3.045 cm/h (MAC); therefore, the compounds cannot be absorbed through human skin \[[@pone.0198476.ref053]\]. In the analysis of human intestinal absorption (HIA), one of the main parameters for new drug candidates, the analyzed alkaloids had values of 96.0% (EPI and EPIIS) and 97.5% (MAC). Some studies \[[@pone.0198476.ref054]--[@pone.0198476.ref055]\] have shown that values between 70% and 100% indicate good intestinal absorption.

The recommended parameters for the prediction of oral absorption of drugs use two permeability models, Caco-2 and MDCK cells. The values obtained for the alkaloids were considered intermediate \[[@pone.0198476.ref056]\]: 27.28 nm/s for MAC, 22.86 nm/s for EPIIS, and 21.83 nm/s for EPI in Caco-2 cells; and 15.79 nm/s for MAC, 16.04 nm/s for EPI, and 9.63 nm/s for EPIIS in MDCK cells.

None of the alkaloids inhibited P-glycoprotein, a protein responsible for the absorption, distribution, metabolism, and excretion of several different drugs \[[@pone.0198476.ref057]\]. In relation to solubility in water and pure water, the alkaloids EPIIS, ISOP, and PILO achieved higher values of 78,158.6 mg/L and 21,880 mg/L, respectively.

Data on the interaction with cytochrome P450 (CYP) protein indicated that all alkaloids were inhibitors of CYP 2C19, CYP 2C9, and CYP 3A4; this reduces the ability of these proteins to metabolize other drugs in the body, which suggests the possible accumulation of their potentiating metabolites to improve the pharmacological effect of these drugs. None of the alkaloids were found to be inhibitors of the CYP AD6 protein.

The characterization of mutagenicity by the Ames test indicated mutagenicity data for all tested alkaloids. However, in specific testing using TA100 and TA1535 cells, the results among the isomers were negative \[[@pone.0198476.ref058]\], and the alkaloids did not produce carcinogenicity in rats or mice.

All the alkaloids were suitable for drug classification by Lipinski's rule (rule of five) and by the World Drug Index (WDI) as having a greater than 90% probability of solubility and permeability \[[@pone.0198476.ref059]\]. The Lipinski rule also has been applied \[[@pone.0198476.ref060]\] to evaluate ligands used in the formation of complexes with PNP. The isomeric alkaloids were classified as having higher binding affinity at 0.1 μM by the lead-like rule, except for MAC, which violated the rule \[[@pone.0198476.ref061]\]. In the CMC-like rule, all alkaloids were classified as qualified \[[@pone.0198476.ref062]\] and, for the MDDR-like rule, as an intermediate between a potential and non-potential drug \[[@pone.0198476.ref063]\].

As poor pharmacokinetic properties are important causes of late-stage failure in drug development, the reduction of these failures through the use of silicon tools such as ADME can lead to early predictions from the optimization of these properties \[[@pone.0198476.ref064]\].

Molecular docking {#sec015}
-----------------

The results of molecular docking of the alkaloids EPI, EPIIS, ISOP, PILO, and MAC with the enzymes of the *S*. *mansoni* worm are shown in [Table 5](#pone.0198476.t005){ref-type="table"}.

10.1371/journal.pone.0198476.t005

###### Molecular affinity parameters of the epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine alkaloids with *S*. *mansoni* enzymes by the autodock program.

![](pone.0198476.t005){#pone.0198476.t005g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Complex\           ΔG~bind~ [^a^](#t005fn001){ref-type="table-fn"}\   Ki [^b^](#t005fn002){ref-type="table-fn"} (μM)   Number of independent docking runs   Number of conformations in the first ranked cluster   Amino acids that interact through hydrogen bonds [^c^](#t005fn003){ref-type="table-fn"}   Amino acids that make hydrophobic interactions [^c^](#t005fn003){ref-type="table-fn"}
  (Protein-ligand)   (kcal mol^-1^)                                                                                                                                                                                                                                                                           
  ------------------ -------------------------------------------------- ------------------------------------------------ ------------------------------------ ----------------------------------------------------- ----------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------
  Up/epiis           -7.68                                              2.36 μM                                          100                                  73                                                    Arg203(2), Gln201, Met231                                                                 Arg121, Gly126, Glu234, Glu232, Ile265, Met233, Phe197, Phe272, Ser125, Thr124-10

  Tgr/epiis          -7.46                                              3.4 μM                                           100                                  11                                                    Glu300, Lys162                                                                            Ala470, Cys159, Leu441, Phe324, Phe474, Pro443, Thr471, Thr472, Tyr296, Val473-10

  Tgr/isop           -7.37                                              3.97 μM                                          100                                  22                                                    Glu300, Lys162(2), Thr472                                                                 Ala470, Cys159, Leu441, Phe324, Phe474, Pro443, Thr471, Tyr296, Val473-9

  Tgr/epi            -7.25                                              4.89 μM                                          100                                  27                                                    Lys162(2), Thr442                                                                         Cys159, Gly158, Glu300, Leu441, Phe280, Phe474, Pro443, Thr472, Tyr296, Val157, Val297, Val473-12

  Up/isop            -7.19                                              5.37 μM                                          100                                  64                                                    Arg50 (2), Arg121, Gln201, Thr124 (2)                                                     Arg121, Gly123, Glu232, Met93, Met231, Met233, Phe197, Phe272-8

  Pnp/epi            -7.18                                              5.46 μM                                          100                                  40                                                    Ala118(2), His88                                                                          Asn117, Asn245, Ala119, Gly120, Gly220, Glu203, His259, Met221, Pro200, Tyr90, Tyr202, Val219--12

  Up/epi             -7.16                                              5.68 μM                                          100                                  33                                                    Arg50, Arg121(2), Thr124, Glu234, Gly46                                                   Gly92, Gly123, Glu232, His91, Met93, Met231, Phe197, Phe272, Ser125--9

  Tgr/pilo           -7.13                                              5.95 μM                                          100                                  20                                                    Lys162, Thr442                                                                            Ala470, Cys159, Glu300, Leu441, Phe474, Pro443, Thr471, Thr472, Tyr296-9

  Pnp/epiis          -7.11                                              6.19 μM                                          100                                  75                                                    Ala118(2), Met221, Ser222                                                                 Asn117, Asn245, Gly120, Gly220, His88, His259, Tyr90, Tyr202, Thr244, Val219-10

  Pnp/pilo           -7.08                                              6.47 μM                                          100                                  41                                                    Ala118, Arg86, Met221                                                                     Ala119, Asn245, Gly34, Gly120, Gly220, Glu203, His88, Ser222, Tyr90, Tyr202, Val219--11

  Mtap/isop          -6.91                                              8.55 μM                                          100                                  8                                                     Ala88, Asn205, Met206                                                                     Ile182, Val204, Ser12, Phe187, Asp232, Gly90, Asp230, Thr229, Cys89, Thr207, His55

  Pnp/isop           -6.83                                              9.84 μM                                          100                                  8                                                     Ala118, Met221                                                                            Asn117, Asn245, Ala119, Arg86, Gly34, Gly120, Gly220, Glu203, His88, Ser35, Ser222, Tyr90, Tyr202, Val219-14

  Up/pilo            -6.74                                              11.54 μM                                         100                                  99                                                    Arg203 (2), Gln201, Met231                                                                Arg121, Gly126, Glu232, Glu234, Ile265, Met233, Phe197, Phe272, Ser125, Thr124-10

  Arg/pilo           -6.64                                              13.47 μM                                         100                                  1                                                     Asn169, His171(2), Gly157                                                                 Glu307, Thr276, Asp158, Asp262, Asp264, His156, Asp211, Glu216, Asn160, Asp213, Gly172-11

  Mtap/epiis         -6.63                                              13.72 μM                                         100                                  1                                                     Asp230, Ser188                                                                            Ala88, Asn205, ILe182, Val204, Phe187, Met206, Gly90, Thr229, Cys89, Asp232

  Mtap/epi           -6.54                                              15.97 μM                                         100                                  33                                                    Ala88, His55, Met206, Ser12                                                               Thr229, Pro63, Phe187, Asp320, Cys89, Val204, Gly90, Thr207, Asn205

  2cb1/epiis         -6.52                                              16.65 μM                                         100                                  2                                                     Gln94, Gly144, Gly269, His270                                                             Cys100, Gly98, Gly143, Leu252, Leu267, Ser99, Trp101, Trp292, Val247

  Mtap/pilo          -6.51                                              16.97 μM                                         100                                  84                                                    Ala88, Asn205, Met206, Val204                                                             Thr229, Cys89, Ile182, Phe187, Asp232, Gly90, Asp230

  Arg/epi            -6.48                                              17.71 μM                                         100                                  54                                                    Ala166, Ser165                                                                            Met173, Asn169, Gly172, His171, Asp158, Asp262, Asp264, Thr276, Asn160, Asp213, Ser167-11

  Arg/epiis          -6.44                                              19.07 μM                                         100                                  16                                                    Asn169 (2)                                                                                Gly172, Ser167, His171, Thr276, Gly157, His156, Glu216, Asp 158, Asp213, Asn160, Asp211, Ser165, Ala166-13

  Hdac8/epi          -6.43                                              19.44 μM                                         100                                  54                                                    \-                                                                                        Tyr99, Asp100, Phe151, Pro19, Tyr153, Lys20, Phe21, Pro102, Phe104, Tyr110, Ser18

  Arg/isop           -6.4                                               20.34 μM                                         100                                  72                                                    Ala166, Asp158, Ser165, Ser167                                                            Asp213, Glu216, Asp211, His156, Gly157, His171, Met173, Asn160, Gly172, Asn169-10

  2cb1/isop          -6.23                                              27.3 μM                                          100                                  8                                                     Gln94, Gly269, Cys100, His270, Gly269                                                     Gly98, Gly143, Gly144, Gly268, His181, Leu252, Leu267, Trp292, Val247

  2cb1/pilo          -6.18                                              29.35 μM                                         100                                  10                                                    Gly144(2), Gln94                                                                          Ala271, Cys100, Gly98, Gly143, Gly244, Gly269, Glu316, His270, Leu146, Trp101

  Up/mac             -6.15                                              31.19 μM                                         100                                  97                                                    Arg50, Gly46, Thr124                                                                      Arg121, Gly92, Gly123, Gln201, Glu232, Glu234, His91, Met93, Met233, Phe197-10

  Hdac8/epiis        -6.14                                              31.78 μM                                         100                                  7                                                     His141, His292,                                                                           Asp184, His142, Gly338, Asp186, Phe216, Gly150, Asp100, Asp285, Typ140, Phe21, Tyr341, His188, Phe151, Asp290

  2cb1/epi           -6.09                                              34.36 μM                                         100                                  10                                                    Gly144(2), Trp101                                                                         Ala271, Cys100, Gln94, Gly98, Gly143, Gly269, Glu316, His270, Leu146

  2cb1/mac           -6.09                                              34.09 μM                                         100                                  2                                                     Ala127, Phe175                                                                            Asp93, Arg92, Gly161, Glu124, Glu165, Lys164, Lys177, Ser126, Ser162, Ser163, Phe103, Tyr173

  Arg/mac            -5.6                                               78.59 μM                                         100                                  100                                                   Asp158, Gly157                                                                            Ser165, Asn169, Asn160, Ser167, Gly172, Ala166, His156, Glu216, Asp211-9

  Mtap/mac           -5.54                                              87.42 μM                                         100                                  100                                                   Ser188                                                                                    Thr229, Cys89, Gly90, Asp230, Asp232, Phe187, Ala88, Asn205, Val204, Met206, Ile182

  Hdac8/pilo         -5.54                                              87.15 μM                                         100                                  2                                                     Tyr99                                                                                     Phe104, Pro102, Tyr153, Asp100, Ser18, Pro19, Lys20, Phe151

  Hdac8/isop         -5.41                                              108.27 μM                                        100                                  14                                                    Asp186, Asp285, His188, Phe216                                                            His292, Phe215, Asp100, Gly150, Tyr341, Phe151, His142

  Hdac8/mac          -5.38                                              113.26 μM                                        100                                  61                                                    \-                                                                                        Asp100, Pro102, Tyr153, Phe104, Tyr110, Lys20, Tyr99, Phe151, Ser18, Pro19

  Tgr/mac            -5.36                                              117.12 μM                                        100                                  1                                                     Cys154, Thr153                                                                            Ala256, Ala445, Asp433, Gly118, Gly258, Gly432, Ile431, Ile434, Leu441, Ser117, Thr442-11

  Pnp/mac            -5.36                                              118.65 μM                                        100                                  13                                                    Asn245, Tyr90                                                                             Asn117, Ala118, Ala119, Gly120, Gly220, His88, Met221, Ser222, Tyr194, Tyr202, Thr244, Val219, Val262-13
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ Binding energy of the best conformation

^b^ Inhibition constant of the best conformation

^c^ Obtained using Ligplot+ software

The enzyme putative uridine phosphorylase (UP) and the EPIIS ligand demonstrated the highest molecular affinity, with a binding energy of −7.68 kcal mol^-1^ and an inhibition constant of 2.36 μM. UP/epiis complex formed hydrogen bonds with three amino acid residues (Arg203, Gln201, and Met231) ([Fig 7](#pone.0198476.g007){ref-type="fig"}). It was also observed that all ligands that interacted with this enzyme had hydrogen bonds or hydrophobic interactions with the amino acid Gln201 in the active site of the protein. The UP protein is a nucleoside phosphorylase that catalyzes the N-ribosidic binding of uridine and thymidine to produce ribose-1-phosphate, uracil, and thymine. This enzyme has important metabolic roles, including protection against ischemia, lipid metabolism, and protein acetylation \[[@pone.0198476.ref065]\].

![Molecular docking of the epiisipilosine alkaloid with the UP enzyme of *S*. *mansoni*.\
a) 2D scheme showing the hydrogen bonds and hydrophobic interactions in the EPIIS-UP complex. b) 3D interactions by hydrogen bonds (Gln201, Met231 and Arg203) in EPIIS. c) 3D conformation of the active site of EPIIS binding in UP enzyme.](pone.0198476.g007){#pone.0198476.g007}

The interaction of the enzyme thioredoxin glutathione reductase (TGR) with the EPIIS ligand showed a binding energy of −7.46 kcal mol^-1^ and an inhibition constant of 3.4 μM. In this complex, only three hydrogen bonds were formed, at the Glu300 (O3) and Lys162 (O2 and O3) residues ([Table 5](#pone.0198476.t005){ref-type="table"}; [Fig 8](#pone.0198476.g008){ref-type="fig"}). The ISOP alkaloid has been shown to also interact with the amino acids Glu300 and Lys162 of EPIIS, in addition to the Thr472 residue, although this was not sufficient to produce higher energy than EPIIS. In the same TGR enzyme, the EPI and PILO alkaloids also interact with the amino acids Lys162 and Thr442, but the position in the active site of the enzyme gave EPI the formation of four hydrogen bonds, which may have offered higher affinity energy for this ligand ([Fig 8](#pone.0198476.g008){ref-type="fig"}). The amino acid of the active site Tyr296 of this enzyme interacted with all ligands, except for MAC ([Fig 8](#pone.0198476.g008){ref-type="fig"}). This same Tyr296 residue was also identified in other studies of the interaction of the TGR enzyme with anti-schistosomal molecules \[[@pone.0198476.ref052]\]. TGR is a chimeric flavoenzyme related to detoxification and parasite survival in the host organism \[[@pone.0198476.ref066]\]; in addition to this, the enzyme participates directly in parasite homeostasis, where it acts as a detoxificant of the reactive oxygen species (ROS) present in the blood vessels of the definitive host and allowing the survival of the worm \[[@pone.0198476.ref064]\].

![Molecular docking showing the active site of the TGR enzyme with the alkaloids and their interactions by hydrogen bonds.\
a) epiisopiloturine, b) epiisopilosine, c) isopilosine, d) pilosine, and e) macaubina.](pone.0198476.g008){#pone.0198476.g008}

The enzyme purine nucleoside phosphorylase (PNP) showed a higher binding affinity with the EPI and EPIIS ligands, with binding energies of −7.18 kcal mol^-1^ and −7.11 kcal mol^-1^, respectively, and inhibition constants of 5.46 μM and 6.19 μM, respectively. In all ligands, it was possible to observe interactions with the amino acid Ala118 at the active site by hydrogen bonds or hydrophobic interaction. This Ala118 amino acid has also been identified in the literature \[[@pone.0198476.ref060]\] as an important residue in the testing of *S*. *mansoni* inhibitors against PNP. In addition, the same authors observed interactions with Met221 and His259 residues, which were also observed to interact with EPIIS and EPI ([Table 5](#pone.0198476.t005){ref-type="table"}). The PNP enzyme of *S*. *mansoni* is essential for the recovery of purine and nucleoside bases in schistosomes; it catalyzes reversible purine phosphorylase (2\'-deoxy) ribonucleosides in the presence of inorganic orthophosphate (Pi) as a second substrate to yield the corresponding purine and (2\'-deoxy) ribose-1-phosphate base as products \[[@pone.0198476.ref060],[@pone.0198476.ref067]\].

The enzyme methylthioadenosine phosphorylase (MTAP) showed higher affinity to ISOP (−6.91 kcal mol^-1^; 8.55 μM) and EPIIS (−6.63 mol^-1^; 13.72 μM). All ligands were shown to have contact with the amino acid Asp230 at the active site of the MTAP enzyme ([Table 5](#pone.0198476.t005){ref-type="table"}). This enzyme uses adenosine as a substrate for the production of adenine. As it is likely the only route for purine production, it represents a promising target for therapies against schistosomiasis \[[@pone.0198476.ref068]\].

The affinity parameters for the enzyme arginase (ARG) showed stronger interactions with PILO (−6.64 kcal mol^-1^, 13.47 μM) and EPI (−6.48 kcal mol^-1^, 17.71 μM). It was also observed that all ligands had hydrogen bond or hydrophobic contact with the amino acid Asp158 of the active site of this enzyme ([Table 5](#pone.0198476.t005){ref-type="table"}). ARG is a binuclear holoenzyme that catalyzes the hydrolysis of L-arginine to L-ornithine and urea, which affects the biosynthesis processes of NO. It regulates all forms of the parasite that interact with the human host, and this enzyme is believed to play a role in the parasitic immune response \[[@pone.0198476.ref069]\].

The formation of an enzyme complex with cathepsin B1 (2CB1) and the EPIIS ligand showed higher affinity with a binding energy of −6.52 kcal mol^-1^ and an inhibition constant of 16.65 μM. The protein-ligand complex showed four hydrogen bonds (Gln94, Gly144, Gly269, and His270) and it was possible to observe the contact of the active site Cys100 amino acid in all ligands except MAC ([Table 5](#pone.0198476.t005){ref-type="table"}). The Cys100 and His270 residues were also observed in the active site of smCB1 complexed with heparin \[[@pone.0198476.ref070]\]. Adult *S*. *mansoni* living in the human cardiovascular system require nutrients from the blood for their growth, development, and reproduction, and smCB1 has been established a protease associated with the intestines of worms that digests host blood proteins as a source of nutrients \[[@pone.0198476.ref070]\].

The histone deacetylase 8 (HDAC8) enzyme demonstrated better affinity parameters with EPI (−6.43 kcal mol^-1^, 19.44 μM) and EPIIS (−6.14 kcal mol^-1^, 31.78 μM). Although EPI binding was higher for this enzyme, it was not possible to verify the presence of hydrogen bonds, only of hydrophobic bonds. The Tyr341 residue of the active site of the HDAC8 enzyme was observed to interact with the EPI and EPIIS linkers ([Table 5](#pone.0198476.t005){ref-type="table"}). Other studies \[[@pone.0198476.ref071]\] have also identified the Tyr341, His292, and His141 residues present in this complex in addition to the importance of the zinc ion. *S*. *mansoni* HDAC8 is an acetyl-L-lysine deacetylase that plays a key role in parasite infectivity, controlling post-transcriptional acetylation and deacetylation in the DNA and gene regulation. These enzymes are linked to potential anticancer, antiviral, antiparasitic, and anti-inflammatory targets \[[@pone.0198476.ref071]--[@pone.0198476.ref072]\].

The data presented in the literature for the five alkaloids corroborate with published experimental studies in which the in vitro activity of the EPIIS alkaloid against *S*. *mansoni* was 3.125 μg/mL \[[@pone.0198476.ref016]\], followed by EPI (300 μg/mL) \[[@pone.0198476.ref020]\], ISOP (500 μg/mL) \[[@pone.0198476.ref016]\], and MAC, which showed no activity up to a concentration of 500 μg/mL \[[@pone.0198476.ref016]\].

Conclusions {#sec016}
===========

The molecular geometries; electronic structures; quantum chemical descriptors; and infrared, Raman, RMN, and UV-Visible spectra of the EPI, EPIIS, ISOP, PILO, and MAC alkaloids have been studied by DFT calculation. The theoretical model B3lyp/6-311++G(d,p) was the most satisfactory to describe all the studied properties, and can be considered suitable for use as a reference for similar structures that showed this pharmacological activity. This work provides new insight to the potential of these molecules as drugs against schistosomiasis, through the identification of previously unknown properties, expansion of the field of study, and enabling the discovery of novel treatments for this disease.

The ADMET profile showed that the EPI alkaloid and its isomers are suitable for the standard Lipinski classification of drugs, with positive parameters in PPB, BBB, HIA and CYP inhibitors, besides having low toxicity and carcinogenicity with more than 90% probability of having good solubility and permeability.

Molecular docking evidenced that the EPIIS alkaloid was the ligand that presented better affinity parameter for UP and TGR proteins, indicating a possible drug candidate for this disease.
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###### Electrostatic energies in (Hartree) of epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine alkaloids using the theoretical models B3lyp/Sdd, B3lyp/6-31+G(d,p) and B3lyp/6-311++G(d,p).
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###### Infrared spectroscopic frequencies (cm^-1^) of the epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine alkaloids and their assignments using the theoretical model B3lyp/6-311++G(d,p).
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###### UV-Vis spectra of epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine alkaloids using the theoretical models B3lyp/Sdd and B3lyp/6-31+G(d,p).

(TIF)
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Click here for additional data file.

###### Infrared and Raman spectra of the epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine alkaloids using the theoretical model B3lyp/6-311++G(d,p).

a\) IR spectra of the five alkaloids, b) zoom of the highest IR peak, c) Raman spectra of the five alkaloids, and d) zoom of the highest Raman peak.

(TIF)
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Click here for additional data file.

###### Infrared spectra of epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine alkaloids using the theoretical models B3lyp/Sdd, B3lyp/6-31+G(d,p), and B3lyp/6-311++G(d,p).

(TIF)
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###### Raman spectra of epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine alkaloids using the theoretical models B3lyp/Sdd, B3lyp/6-31+G(d,p), and B3lyp/6-311++G(d,p).

(TIF)

###### 

Click here for additional data file.

###### Epiisopiloturine, epiisopilosine, isopilosine, pilosine and macaubine ^13^C NMR chemical shifts using the theoretical model B3lyp/6-311++G(d,p).

(TIF)

###### 

Click here for additional data file.
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